News
3h
Zacks Investment Research on MSNAmgen (AMGN) Stock Falls Amid Market Uptick: What Investors Need to Know
In the latest close session, Amgen (AMGN) was down 1.73% at $301.29. The stock's change was less than the S&P 500's daily gain of 0.02%. Meanwhile, the Dow experienced a drop of 0.14%, and the ...
This was the stock's third consecutive day of losses.
In a recently-issued Director Discretionary Denial decision, U.S. Patent and Trademark Office (USPTO) Acting Director Coke ...
Long-term shareholders have already seen significant gains from these stocks, and there's likely much more to come for ...
12h
Zacks Investment Research on MSNAmgen Inc. (AMGN) is Attracting Investor Attention: Here is What You Should Know
Amgen (AMGN) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of ...
In an exclusive interview with Business Today, D. Sridhar Babu, Minister for Information Technology, Industries and Commerce, ...
Amgen Inc. (NASDAQ:AMGN) is one of the top low volatility healthcare stocks to buy now. On July 23, BofA analyst Tim Anderson ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results